Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Radosavljević Davorin"'
Publikováno v:
Medicinski Podmladak, Vol 72, Iss 2, Pp 40-47 (2021)
Lung cancer remains one of the most frequent and the deadliest of malignant diseases throughout the world. Target and immune therapy have revolutionalized the treatment of this disease, but platinum-based chemotherapy still has a place in the treatme
Externí odkaz:
https://doaj.org/article/2c714b8dd9444eafb3e3c08582c8394a
Autor:
Denić Kristina, Tarabar Dino, Obradović Slobodan, Ristić Marija, Spasić Jelena, Radosavljević Davorin, Ugrešić Nenad
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 144, Iss 11-12, Pp 615-620 (2016)
Introduction. Combined use of bevacizumab and conventional anticancer drugs leads to a significant improvement of treatment response in patients with metastatic colorectal carcinoma (CRC). Conventional treatment protocols exert undesired effects o
Externí odkaz:
https://doaj.org/article/227317326bd745ce965156636547d3bf
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 165-167 (2003)
For almost 40 years, the only option for patients with unresectable metastases was treatment with 5-fluorouracil. In the last decade, new drugs became available that changed attitude toward treatment of metastatic CRC as well as the prognosis for som
Externí odkaz:
https://doaj.org/article/2e53572fd5de42ba9cae4b32bd068958
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 157-159 (2003)
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. Advanced gastric carcinoma is often diagnosed. Patients with advanced gastric cancer have a median survival of 6-8 months and chemotherapy is palliati
Externí odkaz:
https://doaj.org/article/df7c3cc5a0cd41c295c85cd19e1e2ea5
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 161-163 (2003)
Adjuvant chemotherapy has been established as the standard of care for patients with node-positive resected colon cancer. 5-fluorouracil modulated with leucovorin given for six months is currently the most widely accepted "standard" regimen. The role
Externí odkaz:
https://doaj.org/article/5010036a08d64451966bd8bdf770155a
Autor:
Radosavljević Davorin Z.
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 137-139 (2002)
Externí odkaz:
https://doaj.org/article/05fc89f508f54ccc8204e1b8266d4659
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 146-146 (2002)
Externí odkaz:
https://doaj.org/article/15f66d639e254b8d87ac628f064905b3
Autor:
Homšek Ana, Radosavljević Davorin, Miletić Nebojša, Spasić Jelena, Jovanović Marija, Miljković Branislava, Stanojković Tatjana, Vučićević Katarina
Background: Treatment of various types of cancer has been improved significantly with the discovery of biological drugs that act as immune checkpoint inhibitors (ICIs). Pembrolizumab is a humanized monoclonal anti- PD-1 antibody currently approved fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b95a2ca0d4ea0c46c9277b2503f062
https://zenodo.org/record/7763405
https://zenodo.org/record/7763405
Autor:
Čavić Milena, Kovačević Tomi, Zarić Bojan, Radosavljević Davorin, Stojanović Goran, Spasić Jelena
The incidence of lung cancer (LC) in Serbia has increased over the past 3 decades. In the period from 1999 to 2008, this increase in incidence was an alarming 27.4%, more so in women than in men. According to official data from the Serbian Cancer Reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::7ee3a1ee9c35457ee4dbd3bd8639b715
https://zenodo.org/record/7386790
https://zenodo.org/record/7386790
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.